The thing with them getting financing is they have actual products that the financiers can see and run numbers on, $25-$50 million is nothing to them when they can see a 10x plus ROI. You have these drug companies with $1 million monthly burn rates that the drugs can end up not getting FDA approval and they are out millions from the backing. I think they are in good shape, a 830am spot Thursday as the only OTC presenting? What's that tell you..
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.